The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Muscular Dystrophy Society of Ireland GLC .

Filed returns
36
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2015: 2 filed returns May–Aug 2016: 1 filed returns Sep–Dec 2016: 1 filed returns Jan–Apr 2017: 1 filed returns May–Aug 2017: 4 filed returns Sep–Dec 2017: 2 filed returns Jan–Apr 2018: 3 filed returns Sep–Dec 2018: 2 filed returns Jan–Apr 2019: 1 filed returns Jan–Apr 2021: 3 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 1 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 1 filed returns Jan–Apr 2024: 1 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 2 filed returns Sep–Dec 2025: 2 filed returns Jan–Apr 2026: 1 filed returns May–Aug 2026: 5 filed returns 2017 2018 2019 2021 2022 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Muscular Dystrophy Society of Ireland GLC Health Review Long-Term Illness Scheme (Public policy or programme) 1 On lobbying.ie
May–Aug 2026 Muscular Dystrophy Society of Ireland GLC Health Improvement of the process for all rare condition and neuromuscular drug reimbursement applications (Public policy or programme) 1 On lobbying.ie
May–Aug 2026 Muscular Dystrophy Society of Ireland GLC Health Prioritise and support an expedited review and reimbursement process for Skyclarys (omaveloxolone), a recently approved treatment for Friedreich’s ataxia. (Public policy or programme) 10 On lobbying.ie
May–Aug 2026 Muscular Dystrophy Society of Ireland GLC Health Reimbursement of Givinostat (Duvyzat®) for boys living with Duchenne Muscular Dystrophy (DMD). (Public policy or programme) 1 On lobbying.ie
May–Aug 2026 Muscular Dystrophy Society of Ireland GLC Health Reimbursement of Risdiplam (Evrydsi) for adults with spinal muscular atrophy (SMA) (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2026 Muscular Dystrophy Society of Ireland GLC Health Reimbursement of treatments for muscular dystrophy and related neuromuscular conditions (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2025 Muscular Dystrophy Society of Ireland GLC Health Written statement in response to the Joint Committee on Health’s call for evidence on issues relating to rare diseases, including access to and reimbursement for medicines. (Public policy or programme) 13 On lobbying.ie
Sep–Dec 2025 Muscular Dystrophy Society of Ireland GLC Health Campaign for equal access to treatments for SMA adults (Public policy or programme) 1 On lobbying.ie
May–Aug 2025 Muscular Dystrophy Society of Ireland GLC Health Campaign for timely assessment of Givinostat for Duchenne muscular dystrophy (Public policy or programme) 0 On lobbying.ie
May–Aug 2025 Muscular Dystrophy Society of Ireland GLC Health Campaign for equal access to treatments for SMA adults (Public policy or programme) 0 On lobbying.ie
Jan–Apr 2025 Muscular Dystrophy Society of Ireland GLC Health MDI urged the HSE to ensure that all children who need ambulance transport to attend vital medical appointments are provided with this service. We requested that a review of current policies be conducted to identify… (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2024 Muscular Dystrophy Society of Ireland GLC Health Communication with office of Marc MacSharry TD regarding parliamentary questions (Public policy or programme) 1 On lobbying.ie
May–Aug 2022 Muscular Dystrophy Society of Ireland GLC Health Attended Neurological Alliance of Ireland audio visual presentation re Campaign for More Neurology Nurses at Leinster House, as a partner organisation. (Matters involving public funds) 4 On lobbying.ie
Jan–Apr 2022 Muscular Dystrophy Society of Ireland GLC Health Sought support in securing investment in nurse specialists across neurology services in Ireland (Matters involving public funds) 16 On lobbying.ie
Sep–Dec 2021 Muscular Dystrophy Society of Ireland GLC Health Signatory to joint letter/email seeking support for UN Resolution on 'Addressing the Challenges of Persons Living with a Rare Disease and their Families'. (Public policy or programme) 15 On lobbying.ie
May–Aug 2021 Muscular Dystrophy Society of Ireland GLC Health Call to prioritise children with muscular dystrophy/neuromuscular conditions in the rollout of vaccines for 12 to 15-year-olds. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2021 Muscular Dystrophy Society of Ireland GLC Health Calling for promises in the Programme for Government to be fulfilled and for the delivery of a range of measures relating to rare diseases. (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2021 Muscular Dystrophy Society of Ireland GLC Health Seeking vaccine prioritisation from a coalition of 19 patient, carer and medically vulnerable group organisations. The coalition called for people with disabilities and chronic and/or rare condition(s) to be given… (Public policy or programme) 15 On lobbying.ie
Jan–Apr 2021 Muscular Dystrophy Society of Ireland GLC Health Call to prioritise people with muscular dystrophy/neuromuscular conditions who are very high risk / extremely medically vulnerable and high risk from Covid-19 for vaccination, as well as their unpaid/informal carers. (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2019 Muscular Dystrophy Society of Ireland GLC Health Advocating on behalf of a member for a Primary Medical Certificate (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2018 Muscular Dystrophy Society of Ireland GLC Health Access to orphan drug Spinraza for people with Muscular Dystrophy (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2018 Muscular Dystrophy Society of Ireland GLC Health Access to orphan drugs translarna and spiranza for people with Muscular Dystrophy (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2018 Muscular Dystrophy Society of Ireland GLC Health Access to medications - Nusinersen (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2018 Muscular Dystrophy Society of Ireland GLC Health Evaluation of orphan drugs (Legislation) 1 On lobbying.ie
Jan–Apr 2018 Muscular Dystrophy Society of Ireland GLC Health Access to medicines (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2017 Muscular Dystrophy Society of Ireland GLC Health Lobbying for the reimbursement of Translarna (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2017 Muscular Dystrophy Society of Ireland GLC Health Member's of Dail and Seanad Eireann were invited to a lobbying day by MDI to meet members of their constituency and discuss individual issue. A number of requests were made by MDI in a briefing document presented to all… (Public policy or programme) 30 On lobbying.ie
May–Aug 2017 Muscular Dystrophy Society of Ireland GLC Health Lobbying for the reimbursement of Translarna (Matters involving public funds) 6 On lobbying.ie
May–Aug 2017 Muscular Dystrophy Society of Ireland GLC Health Lobbying in Relation to the assessment process for the reimbursement of Orphan Drugs (Matters involving public funds) 1 On lobbying.ie
May–Aug 2017 Muscular Dystrophy Society of Ireland GLC Health Lobbying in relation to inequality of access to orphan drugs between Ireland and other European countries (Public policy or programme) 1 On lobbying.ie
May–Aug 2017 Muscular Dystrophy Society of Ireland GLC Health Lobbying for the reimbursement of Translarna (Matters involving public funds) 3 On lobbying.ie
Jan–Apr 2017 Muscular Dystrophy Society of Ireland GLC Health Lobbying in relation to the Reimbursement of Translarna (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2016 Muscular Dystrophy Society of Ireland GLC Health Lobbying in relation to the reimbursement of Translarna (Matters involving public funds) 1 On lobbying.ie
May–Aug 2016 Muscular Dystrophy Society of Ireland GLC Health Requesting the reimbursement of Translarna for Duchenne Muscular Dystrophy (Matters involving public funds) 15 On lobbying.ie
Sep–Dec 2015 Muscular Dystrophy Society of Ireland GLC Health Member's of Dail and Seanad Eireann were invited to a lobbying day by MDI to meet members of their constituency and discuss individual issue. A number of requests were made by MDI in a briefing document presented to all… (Public policy or programme) 28 On lobbying.ie
Sep–Dec 2015 Muscular Dystrophy Society of Ireland GLC Health Matters relating to accessing equipment for individual members with a disability (Matters involving public funds) 3 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 36 100.0%